Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
- 1 August 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 119 (2) , 223-230
- https://doi.org/10.1111/j.1365-2133.1988.tb03204.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Cyclosporine improves psoriasis in a double-blind studyJAMA, 1986
- Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.The Journal of Experimental Medicine, 1986
- Effect of 1α,25-Dihydroxyvitamin D3 on the Morphologic and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Serum-Free ConditionsJournal of Investigative Dermatology, 1986
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- Epidermal T lymphocytes and HLA-DR expression in psoriasisBritish Journal of Dermatology, 1984
- Characterization of Mononuclear Cell Infiltrates in Psoriatic LesionsJournal of Investigative Dermatology, 1978
- Biological activity of 1α,24‐dihydroxycholecalciferol; A new synthetic analog of the hormonal form of vitamin DFEBS Letters, 1977
- Metabolism of 1α-hydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3 in perfused rat liverBiochemical and Biophysical Research Communications, 1975